USP7 and acute lymphoblastic leukemia: Modulating LCK activity via USP11 silencing or USP7 inhibition sensitized T-ALL cells to the GC treatment, as evidenced by inhibition of cell growth caused by an increase in apoptosis upon GC treatment (fig.